首页> 外国专利> SCREENING METHOD FOR CANCER THERAPEUTIC AGENT TARGETING JAK2-STAT3-KDM3A SIGNALING PATHWAY

SCREENING METHOD FOR CANCER THERAPEUTIC AGENT TARGETING JAK2-STAT3-KDM3A SIGNALING PATHWAY

机译：癌症治疗剂靶向JAK2-STAT3-KDM3A信号通路的筛选方法

页面导航

摘要
著录项
相似文献

摘要

The present invention provides a screening method for a cancer therapeutic agent targeting a JAK2-STAT3-KDM3A signaling pathway. The method according to the present invention can control a JAK2-STAT3 signaling pathway which is closely related to development and progression of malignant tumors through inhibition of KDM3A phosphorylation, thereby enabling the development of an effective new cancer therapeutic agent.;COPYRIGHT KIPO 2020

机译：本发明提供了靶向JAK2-STAT3-KDM3A信号传导途径的癌症治疗剂的筛选方法。根据本发明的方法可以通过抑制KDM3A磷酸化来控制与恶性肿瘤的发生和发展密切相关的JAK2-STAT3信号传导途径，从而使得能够开发有效的新型癌症治疗剂。COPYRIGHTKIPO 2020

著录项

公开/公告号KR20200057228A

专利类型
公开/公告日2020-05-26

原文格式PDF
申请/专利权人 SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION;
展开▼

申请/专利号KR20180141315
发明设计人 BAEK SUNG HEE;KIM DONGHA;KIM HYUNKYUNG;
展开▼

申请日2018-11-16
分类号G01N33/50;G01N33/68;
国家 KR
入库时间 2022-08-21 11:07:02

相似文献

专利
外文文献
中文文献